A
Aveo Pharmaceuticals Inc
F:VPA1
Aveo Pharmaceuticals Inc
F:VPA1
Price:
13.77
EUR
-0.4%
Market Closed
Market Cap:
€478.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Aveo Pharmaceuticals Inc
F:VPA1
|
US |
|
Udayshivakumar Infra Ltd
NSE:USK
|
IN |
|
Natuzzi SpA
NYSE:NTZ
|
IT |
|
W
|
Woodside Petroleum Ltd
OTC:WOPEF
|
AU |
|
Plexus Holdings PLC
LSE:POS
|
UK |
|
A
|
Apollo Healthcare Corp
TSX:AHC
|
CA |
|
R
|
R Stahl AG
XHAM:RSL2
|
DE |
|
Sky Gold Corp
XTSX:SKYG
|
CA |
|
Eastern Pioneer Driving School Co Ltd
SSE:603377
|
CN |
|
G
|
Guangdong Yueyun Transportation Co Ltd
HKEX:3399
|
CN |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VPA1's stock price target?
Not Available
VPA1 doesn't have any price targets made by Wall Street professionals.
What is Aveo Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
208%
208%
For the last 8 years the compound annual growth rate for Aveo Pharmaceuticals Inc's revenue is 55%. The projected CAGR for the next 1 year is 208%.
